Sarepta Therapeutics(CH:AB3A)
CHF 12.630.00 (0.00%)
CH:AB3A
Sarepta Therapeutics earnings date
CHF 12.63
At close:0.00 (0.00%)
Sarepta Therapeutics (AB3A) Q1 2026 Earnings Report
0 Followers
CH:AB3A Q1 2026 EPS Results
- Actual EPS
- CHF 2.43
- Consensus EPS
- CHF 0.82
- Beat/Miss
- Beat by +CHF 1.61
- One Year Ago EPS
- -CHF 3.88
CH:AB3A Q1 2026 Revenue Results
- Actual Revenue
- CHF 616.21M
- Expected Revenue
- CHF 399.81M
- Beat/Miss
- Beat by +CHF 216.40M
- YoY Revenue Growth
- -1.89%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/06/2026
- Time
- After Close
- Conference Call
- Wednesday, May 6, 2026
CH:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
CH:AB3A Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.31- | -3.31 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.07-0.23 | -1.52 | 85.00% (+1.29) | |
| Aug 05, 2026 | 2026 (Q2) | 0.18-0.04 | 1.59 | -102.65% (-1.64) | |
| May 06, 2026 | 2026 (Q1) | 0.822.43 | -3.88 | 162.61% (+6.31) | |
| Feb 25, 2026 | 2025 (Q4) | -1.01-3.31 | 1.26 | -362.00% (-4.58) | |
| Nov 03, 2025 | 2025 (Q3) | -0.61-1.52 | 0.29 | -629.41% (-1.80) | |
| Aug 06, 2025 | 2025 (Q2) | 0.701.59 | 0.06 | 2600.00% (+1.53) | |
| May 06, 2025 | 2025 (Q1) | -2.70-3.88 | 0.31 | -1343.24% (-4.19) | |
| Feb 26, 2025 | 2024 (Q4) | 1.591.26 | 0.4 | 219.15% (+0.87) | |
| Nov 06, 2024 | 2024 (Q3) | -0.060.29 | -0.39 | 173.91% (+0.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


